In a recent study, scientists from The Jackson Laboratory (JAX) and UConn Health not only show how cancer hijacks this tightly regulated splicing and rearranging of RNA but also introduce a potential therapeutic strategy that could slow or even shrink aggressive and hard-to-treat tumors. Thi
Glioblastoma is an extremely aggressive brain tumour that is currently incurable. Cancer doctors can increase their patients' life expectancy with surgeries, radiation, chemotherapy, or surgical procedures. Nonetheless, half of patients die within a year of diagnosis.
According to a recent study, medications intended to treat blood and other malignancies may also increase the effectiveness of radiation therapy for low-grade brain tumours in adults.
A research group at the University of Seville's Department of Biochemistry and Molecular Biology has achieved great progress by identifying the critical role of the protein Galectin-3 in the progression of several forms of brain tumours.
The new device, the size and shape of a grain of rice, can run dozens of trials at once to evaluate the impact of novel medicines on some of the most difficult-to-treat brain malignancies.
A recent study from the University of Michigan Department of Neurosurgery and Rogel Cancer Centre demonstrates encouraging preliminary findings that a therapy combining cell-killing and immune-stimulating drugs is safe and effective in extending survival for patients with gliomas, a particu
A study performed by UCLA Jonsson Comprehensive Cancer Centre researchers gave new light on why tumours that have spread to the brain from other parts of the body react to immunotherapy whereas glioblastoma, an aggressive brain cancer, does not.
For the first time, researchers discovered a potential drug candidate that improved outcomes for patients suffering from a type of childhood brain tumour that has no effective treatment. When compared to previous patients, the compound, called ONC201, nearly doubled survival for patients wit
Glioblastoma, the most prevalent and lethal type of brain cancer, spreads quickly, invading and destroying healthy brain tissue. The tumour shoots malignant tendrils into the brain, making surgical removal of the tumour extremely difficult or impossible.